Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 31-40 of 9364

Page
per page
  1. E 64d
    A1903 E 64d
     8 Citation
    Summary: Cysteine protease inhibitor
      insoluble in H2O; ≥17.12 mg/mL
  2. Avanafil
    A4334 Avanafil
     1 Citation
    Target: Phosphodiesterases (PDEs)
    Summary: PDE5 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL
  3. Z-DEVD-FMK
    A1920 Z-DEVD-FMK
     38 Citation
    Target: Caspases
    Summary: Caspase-3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥60 mg/mL
  4. Cathepsin S inhibitor
    A3284 Cathepsin S inhibitor
     1 Citation
    Target: Cathepsins
    Summary: Blocks MHCII antigen presentation
      ≥24.25 mg/mL
  5. Exendin-4
    A3408 Exendin-4
     3 Citation
    Target: Glucagon-like peptide 1 (GLP-1) receptors
    Summary: GLP-1 activator
      ≥145 mg/mL
  6. Safinamide
    A3784 Safinamide
    Summary: MAO-B inhibitor
      ≥32.3 mg/mL
  7. Urolithin A
    B7945 Urolithin A
      ≥22.8 mg/mL
  8. Oleandomycin
    C3213 Oleandomycin
    Summary: macrolide antibiotic
      Soluble in DMSO
  9. Mebendazole
    C4087 Mebendazole
    Summary: broad-spectrum anthelmintic that inhibits intestinal microtubule synthesis
      insoluble in H2O; insoluble in EtOH; ≥13 mg/mL
  10. Amyloid Beta-Peptide (1-40) (human)
    A1124 Amyloid Beta-Peptide (1-40) (human)
     1 Citation
    Summary: residues 1-40 of human amyloid-beta
      insoluble in EtOH; ≥23.8 mg/mL

Items 31-40 of 9364

Page
per page